In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 2, 1996, Pages 137-144

  Gobeil, F ^a   Filteau, C ^a   Pheng, L H ^a   Jukic, D ^a   Nguyen Le, X K ^a   Regoli, D ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

antagonists; blood pressure; bradykinin B2 receptor subtypes; guinea pig; isolated organs; kinins; rabbit; receptor agonists

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ICATIBANT; [[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; GUINEA PIG; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029886444     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-001     Document Type: Article

References (35)

1. Barabé, J., Marceau, F., Thériault, B., Drouin, J.N., and Regoli D. 1979. Cardiovascular actions of kinins in the rabbit. Can. J. Physiol. Pharmacol. 57: 78-91.
2. Canadian Council on Animal Care. 1993. Guide to the care and use of experimental animals. Vol. 1. 2nd ed. Edited by E.D. Olfert, B.M. Cross, and A.A. McWilliam. Canadian Council on Animal Care, Ottawa, Ont.
3. Drapeau, G., and Regoli, D. 1988. Synthesis of bradykinin analogues. Methods Enzymol. 163: 263-272.
4. Drapeau, G., Chow, A., and Ward, P.E. 1991. Metabolism of bradykinin analogs by angiotensin 1 converting enzyme and carboxypeptidase N. Peptides, 12: 631-638.
5. 1 receptors for kinins. J. Pharmacol. Exp. Ther. 266: 192-198.
6. 3 receptor. Mol. Pharmacol. 36: 1-8.
7. Ferreira, S.H., and Vane, J.R. 1967. The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cats. Br. J Pharmacol. Chemother. 30: 417-424.
8. Furchgott, R.F., and Bhadrakom, S. 1953. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol and other drugs. J. Pharmacol. Exp. Ther. 108: 124-143.
9. Gabbiani, G., Badonnel, M.C., and Majno, G. 1970. Intraarterial injections of histamine, serotonin and bradykinin: a topographic study of vascular leakage. Proc. Soc. Exp. Biol. Med. 135: 447-452.
10. Gaudreau, P., Barabé, J., St-Pierre, S., and Regoli, D. 1981. Pharmacological studies of kinins on venous smooth muscles. Can. J. Physiol. Pharmacol. 59: 371-379.
11. Gobeil, F., and Regoli, D. 1994. Characterization of kinin receptors by bioassays. Braz. J. Med. Biol. Res. 27: 1781-1791.
12. Hess, J.F., Borkowski, J.A., Young, G.S., Strader, C.D., and Ransom, R.W. 1992. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184(1): 260-268.
13. 2 bradykinin receptors. Mol. Pharmacol. 45: 1-8.
14. Hock, F.J., Wirth, K., Albus, U., Linz, W., Gerhards, H.J., Wiemer, G., Henke, S., Breipohl, G., Konig, W., Knolle, J., and Scholkens, B.A. 1991. Hoe 140, a new potent and long-acting bradykinin antagonist: in vitro studies. Br. J. Pharmacol. 102: 769-773.
15. Liona, I., Vavrek, R.J., Stewart, J.M., and Huidobro-Toro, J.P. 1987. Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: evidence for different structural prerequisites. J. Pharmacol. Exp. Ther. 241: 608-614.
16. 2 receptors on the venoconstrictor action of bradykinin. J. Pharmacol. Exp. Ther. 269: 1136-1143.
17. 2 bradykinin receptor. Proc. Natl. Acad. Sci. U.S.A. 88: 7724-7728.
18. Mombouli, J.V., and Vanhoutte, P.M. 1995. Kinins and endothelial control of vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 35: 679-705.
19. Moncada, S., Palmer, R.M., and Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142.
20. Rang, H.P. 1964. Stimulant actions of volatile anesthetics on smooth muscle. Br. J. Pharmacol. 22: 356-365.
21. Regoli, D., and Barabé, J. 1980. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32: 1-46.
22. Regoli, D., Jukic, D., Gobeil, F., and Rhaleb, N.E. 1993. Receptors for bradykinin and related kinins: a critical analysis. Can. J. Physiol. Pharmacol. 71: 556-567.
23. Regoli, D., Boudon, A., and Fauchere, J.L. 1994a. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46: 551-599.
24. 2 subtypes. Life Sci. 55: 735-749.
25. Rhaleb, N.-E., Dion, S., Barabé, J., Rouissi, N.E., Jukic, D., Drapeau, G., and Regoli, D. 1989. Receptors for kinins in isolated arterial vessels of dogs. Eur. J. Pharmacol. 162: 419-427.
26. Rhaleb, N.-E., Drapeau, G., Jukic, D., Rouissi, N., and Regoli, D. 1990. Structure-activity studies of bradykinin and related peptides. Agonists. Br. J. Pharmacol. 99: 445-448.
27. 8] bradykinin). Eur. J. Pharmacol. 210: 115-120.
28. Rifo, J., Pourrat, M., Vavrek, R.J., Stewart, J.M., and Huidobro-Toro, J.P. 1987. Bradykinin receptor antagonists used to characterize the heterogeneity of bradykinin-induced responses in rat vas deferens. Eur. J. Pharmacol. 142: 305-312.
29. Rocha, M., and Silva, E. 1970. Kinin hormones. C.C. Thomas, Springfield, Ill.
30. Schild, H.O. 1947. pA, a new scale for the measurement of drug antagonism. Br. J. Pharmacol. 2: 189-202.
31. Schild, H.O. 1973. Receptor classification with special reference to beta adrenergic receptors. In Drug receptors. Edited by H.P. Rang, University Park Press, Baltimore, Md. pp. 1129-1136.
32. 2 bradykinin antagonists. In Bradykinin antagonists. Edited by R.M. Burch. Marcel Dekker Inc., New York. pp. 51-96.
33. Tallarida, R.J., and Murray, R.B. 1987. Manual of pharmacologic calculations with computer programs. 2nd ed. Springer-Verlag, New York.
34. Vane, J.R. 1969. The release and fate of vasoactive hormones in the circulation. Br. J. Pharmacol. 35: 209-242.
35. Vavrek, R.J., and Stewart, J.M. 1985. Competitive antagonists of bradykinin. Peptides, 6: 161-164.